Results 91 to 100 of about 31,226 (229)

The results of aflibercept therapy as a first line treatment of age-related macular degeneration

Journal of Current Ophthalmology, 2019
Purpose: To report the results of aflibercept treatment in treatment-naive neovascular age-related macular degeneration (AMD) patients and suggest a suitable treatment algorithm for routine clinical practice.
Erkan Unsal, Mehmet Ozgur Cubuk
doaj   +1 more source

Consensus on age‐related macular degeneration course curricula for general ophthalmologists and non‐ophthalmologist clinical staff: A Delphi study

Acta Ophthalmologica, Volume 104, Issue 3, Page e269-e276, May 2026.
Abstract Purpose To define the curriculum content for two interactive learning courses on age‐related macular degeneration (AMD): (1) an advanced course tailored for general ophthalmologists and (2) a basic course for non‐ophthalmologist healthcare staff.
Filip Sommer‐Lind, Yousif Subhi, Anna S. Vergmann, Monica Lövestam‐Adrian, Nis Andersen, Enrico Borrelli, Lasse J. Cehofski, Mads K. Falk, Øystein K. Jørstad, Kai Kaarniranta, Musa Y. Kaya, Morten B. Larsen, Gregor S. Reiter, Miklos Schneider, Henrik Vorum, Jakob Grauslund, VILMA‐AMD Study Group, Anja Bate, Anja Lund, Anssam Al‐Sharmary, Audrone Rimsaite, Charlotte Melsen, Charlotte Mikkelsen, Christoffer Rud Sørensen, Elizabeth Visby, Hanne Roed, Henrik Kemp, Henrik Melsom, Jeanet Lomholt, Jens Lundgaard Andresen, Jesper Skov, Karen Laursen, Kristian Lundberg, Lena Andersen, Lene Bang Jensen, Line Gerken, Line Petersen, Louise Munkholm, Marie Krogh, Mette Borg Madsen, Mikkel Lyngholm, Per Flesner, Pernille Oversø Hansen, Peter Fahmy, Sathuja Prasad, Søren Berndt Hansen, Søren Kromann Abildgaard   +46 more
wiley   +1 more source

Power and clinical utility of mesopic microperimetry analysis strategies in age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 3, Page e292-e299, May 2026.
Abstract Purpose This study evaluates whether mesopic microperimetry (MMP) provides a more robust measure of retinal function compared to visual acuity (VA) in age‐related macular degeneration (AMD) clinical trials, with a focus on optimal analysis strategies. Method Fellow‐eyes of unilateral neovascular AMD were prospectively studied.
Francesco Cinque, Jeroen Pas, Mahfam Shahabi, Laurens Sluijterman, Sofie ten Brink, Anita de Breuk, Thomas J. Heesterbeek, Caroline Klaver, Carel Hoyng, Yara Lechanteur   +9 more
wiley   +1 more source

Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration

Journal of Ophthalmology, 2015
Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes.
Eui Chun Kang, Hyoung Jun Koh
doaj   +1 more source

Ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade [PDF]

, 2009
PURPOSE: To investigate the efficacy of vascular endothelial growth factor-specific (VEGF) monoclonal antibodies in the treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) that does not extend beneath the foveal ...
Amaro, Miguel Hage, Roller, Aaron Brock
core   +3 more sources

Intravitreal bevacizumab for neovascular age-related macular degeneration

Philippine Journal of Ophthalmology, 2009
Objectives: Anti-vascular endothelial growth factor (anti-VEGF) drugs delivered intravitreally have been proven effective and safe for the treatment of patients diagnosed with neovascular age-related macular degeneration (ARMD).
Junn R. Pajarillo, MD, Harvey S. Uy,MD, Milagros H. Arroyo MD, MPH   +2 more
doaj  

The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited [PDF]

, 2017
BACKGROUND: To compare a near decade of follow-up, newer control cohort data, use of both the societal and third party insurer cost perspectives, and integration of unilateral/bilateral therapy on the comparative effectiveness and cost-effectiveness of ...
Adam Turpcu, Gary C. Brown, Heidi B. Lieske, Melissa M. Brown, Yamina Rajput   +4 more
core   +1 more source

Switching to Faricimab or High‐Dose Aflibercept for Neovascular AMD in High‐Demand Patients: Impact on Injection Interval in a Real‐World Cohort

Clinical &Experimental Ophthalmology, EarlyView.
Zachary George Angus, Yin‐Zhi Lee, Sukhpal Singh Sandhu, Robyn Troutbeck, Jonathan Yeoh, Daniel Chiu, Manishka Jayasundera, Jaesser Tan, Sanjeewa Wickremasinghe   +8 more
wiley   +1 more source

Characterization of retinal pigment epithelium layer in healthy and diseased retinas with high‐resolution adaptive optics transscleral flood illumination imaging

Acta Ophthalmologica, Volume 104, Issue 3, Page e277-e291, May 2026.
Abstract Purpose The retinal pigment epithelium (RPE) is critical in the pathophysiology of retinal diseases, such as age‐related macular degeneration. Adaptive optics transscleral flood illumination (AO‐TFI) offers rapid, detailed morphometric characterization of the RPE layer.
Leila Sara Eppenberger, Safa Mohanna, Sohrab Ferdowsi, Sonja Simon‐Zoula, Oliver Pfäffli, Christoph Amstutz, Lucas M. Bachmann, Michael A. Thiel, Martin K. Schmid   +8 more
wiley   +1 more source

Reliability of colour perimetry to assess macular pigment optical density in age-related macular degeneration

, 2020
Producción CientíficaABSTRACT: BACKGROUND: The aim of this study was to determine the intra-session repeatability and inter-examiner reproducibility of the colour perimetry technique when assessing in vivo macular pigment optical density in age-related ...
Coco Martín, Rosa María, Fernández Martínez, Itziar, López Miguel, Alberto, Pichel Mouzo, María Dolores, Plata Cordero, María   +4 more
core   +2 more sources